Connecting Global Capital to Drive Biotech Innovation in Asia

Jinyi Interconnectivity Co., Ltd., a subsidiary established in Hong Kong in 2025 by the renowned global venture capital firm Index Ventures, serves as the core vehicle for its strategic expansion into the Asian market. We are a dedicated investment platform focusing on Asia's biopharma and tech-enabled healthcare startups, committed to bridging world-class capital, networks, and expertise with the region's dynamic innovation engine to collectively shape the future of healthcare.

  1. Powerful Global Heritage & Local Insight

As a pivotal arm of Index Ventures in Asia, Jinyi Interconnectivity inherits a robust investment DNA:

· Preeminent Parental Backing: Since its founding in 1996, Index Ventures has backed over 100 unicorn companies, including notable names like Revolut, Figma, and BioNTech, building a distinguished track record and deep sector insight in life sciences and AI.

· Unique Synergistic Edge: We benefit not only from the capital support of our parent firm but also from seamless access to its global resource network, professional post-investment management systems, and nearly three decades of venture capital experience.

 2. Precisely Focused Investment Domains

We deeply concentrate on the most disruptive frontier areas within Asia's biopharma landscape. Our primary investment sectors include:

· Advanced Therapies: Gene therapy, Cell and Gene Therapy (CGT), Precision medicine.

· Technology Enablers: AI-driven drug discovery, Digital health management platforms.

· Key Focus Areas: Cancer therapeutics, Gut microbiome research, Rare disease treatments.

We employ a multi-stage investment strategy, covering the full lifecycle from early-stage R&D to mature commercialization, aiming to identify and nurture the industry leaders that will define tomorrow.

 3. Core Competitive Advantages

· Market Edge: We are deeply embedded in one of the world's most promising biopharma markets – Asia, particularly China. This region boasts a vast patient population, rapidly growing healthcare demands, continuously improving regulatory landscapes, and explosively expanding innovation capabilities.

· Background Strength: Direct backing from Index Ventures provides us with global brand credibility, substantial capital support, and mature fund operational experience, offering powerful endorsement and resource security for our portfolio companies.

· Geographical Advantage: Headquartered in Hong Kong, we leverage the city's status as an international financial hub, featuring robust legal frameworks, strong intellectual property protection, and a unique position as a bridge connecting Mainland China and the world. This offers an optimal gateway for cross-border capital and technology transfer.

· Expert Team: We have assembled a team that blends international perspective with local expertise, possessing deep sector understanding, professional investment judgment, and the capability to provide comprehensive value-added services to our portfolio companies.